Publications of Y. Genzel
All genres
Conference Paper (15)
101.
Conference Paper
Comparing Vero and MDCK cells for influenza A virus production in microcarrier systems. In: Cells and Culture: Proceedings of the 20th ESACT Meeting, pp. 635 - 638 (Ed. Noll, T.). 20th ESACT Meeting, Dresden, Germany, June 17, 2007 - June 20, 2007. (2010)
102.
Conference Paper
Two-population CFD simulation: microcarrier system for adherent cell growth in Wave Bioreactors. In: 4th International Conference on Population Balance Modelling: PBM 2010, pp. 667 - 681. 4th International Conference on Population Balance Modelling, Berlin, Germany, September 15, 2010 - September 17, 2010. (2010)
103.
Conference Paper
Metabolite Analysis in Mammalian Cells: How to generate reliable data sets? In: Cells and Culture: Proceedings of the 20th ESACT Meeting, pp. 397 - 406 (Ed. Noll, T.). 20th ESACT Meeting, Dresden, Germany, June 17, 2007 - June 20, 2007. (2010)
104.
Conference Paper
Single-cell approach in influenza vaccine production: apoptosis and virus protein production. In: Cells and Culture: Proceedings of the 20th ESACT Meeting, pp. 25 - 28 (Ed. Noll, T.). 20th ESACT Meeting, Dresden, Germany, June 17, 2007 - June 20, 2007. (2010)
105.
Conference Paper
Proteomic analysis of influenza A virus infected mammalian cells by 2D-DIGE. In: Cells and Culture: Proceedings of the 20th ESACT Meeting, pp. 429 - 432 (Ed. Noll, T.). 20th ESACT Meeting, Dresden, Germany, June 17, 2007 - June 20, 2007. (2010)
106.
Conference Paper
Metabolic flux distribution during growth of adherent growing MDCK cells in different media. In: Cells and Culture: Proceedings of the 20th ESACT Meeting, pp. 459 - 462 (Ed. Noll, T.). 20th ESACT Meeting, 2007-06-17, June 20, 2007. (2010)
107.
Conference Paper
Serum-free influenza vaccine production with MDCK cells in wave-bioreactor and 5L-stirred tank bioreactor. In: Cell Technology for Cell Products: Proceedings of the 19th ESACT Meeting, pp. 563 - 565 (Ed. Smith, R.). 19th ESACT Meeting , Harrogate, UK, June 05, 2005 - June 08, 2005. Springer, Dordrecht, The Netherlands (2007)
108.
Conference Paper
Influenza Vaccines: Challenges in Mammalian Cell Culture Technology. In: Cell Technology for Cell Products: Proceedings of the 19th ESACT Meeting, pp. 503 - 508 (Ed. Smith, R.). 19th ESACT Meeting, Harrogate, UK, June 05, 2005 - June 08, 2005. Springer, Dordrecht, The Netherlands (2007)
109.
Conference Paper
Monitoring of Cell Physiology in Influenza Vaccine Production by Flow Cytometry. In: Cell Technology for Cell Products: Proceedings of the 19th ESACT Meeting, pp. 531 - 533 (Ed. Smith, R.). 19th ESACT Meeting, Harrogate, UK, June 05, 2005 - August 06, 2005. Springer, Dordrecht, The Netherlands (2007)
110.
Conference Paper
Glutamine-free media for vaccine production processes. In: Animal Cell Technology meets Genomics: Proceedings ot the 18th ESACT Meeting, pp. 767 - 770 (Eds. Godia, F.; Fussenegger, M.). 18th ESACT Meeting , Granada, Spain, May 11, 2003 - May 14, 2003. (2005)
111.
Conference Paper
Animal cell cultures for the production of viral vaccines. In: GVC/DECHEMA Vortrags- und Diskussiontagung "Zellkulturen: vom biologischen System zum Produktionsprozess", pp. 32 - 35. GVC/DECHEMA : Vortrags- und Diskussionstagung, Bad Dürkheim, Deutschland, May 26, 2003 - May 28, 2003. (2003)
112.
Conference Paper
Development of bioprocess concepts on vaccine production: influenza virus as an example. In: Animal cell technology: from target to market, pp. 344 - 346 (Eds. Lindner-Olsson, E.; Chatzissavidou, N.; Luellau, E.). 17th ESACT Meeting, Tylösand, Sweden, June 10, 2001 - June 14, 2001. (2001)
Meeting Abstract (15)
113.
Meeting Abstract
Continuous mode of production for two classes of defective interfering influenza A virus particles as antiviral candidates. In Integrated Continuous Biomanufacturing IV, 76. Biomanufact IV, Ocean Edge Resort Brewster (Cape Cod), Massachusetts, USA , October 06, 2019 - October 10, 2019. (2019)
114.
Meeting Abstract
A single-use chromatographic purification platform for viral gene transfer vectors & viral vaccines. In Proceedings Advancing Manufacture of Cell and Gene Therapies VI, 92. Advancing Manufacture of Cell and Gene Therapies VI, Loews Coronado Bay Hotel Coronado, California, USA, January 27, 2019 - January 31, 2019. (2019)
115.
Meeting Abstract
Highly efficient influenza virus production: A MDCK-based high-cell-density process. In Vaccine Technology VII, 13. Vaccine Technology VII, Mont Tremblant, Canada, June 17, 2018 - June 22, 2018. (2018)
116.
Meeting Abstract
Orbital shaken bioreactor for influenza A virus production in high cell density cultivations. In Vaccine Technology VII, 40. Vaccine Technology VII, Mont Tremblant, Canada, June 17, 2018 - June 22, 2018. (2018)
117.
Meeting Abstract
A new porcine suspension cell line (PBG.PK-21) provides efficient production for influenza and yellow fever vaccine viruses. In Vaccine Technology VII, 48. Vaccine Technology VII, Mont Tremblant, Canada, June 17, 2018 - June 22, 2018. (2018)
118.
Meeting Abstract
Purifying viruses with a sheet of paper: Single-use steric exclusion chromatography as a capture platform for vaccine candidates. In Vaccine Technology VII, 128. Vaccine Technology VII, Mont Tremblant, Canada, June 17, 2018 - June 22, 2018. (2018)
119.
Meeting Abstract
Flavivirus production in perfusion processes using the EB66® cell line. In Vaccine Technology VII, 80. Vaccine Technology VII, Mont Tremblant, Canada, June 17, 2018 - June 22, 2018. (2018)
120.
Meeting Abstract
Efficient influenza vaccine manufacturing: Single MDCK suspension cells in chemically defined medium. In Vaccine Technology VII, 5. Vaccine Technology VII, Mont Tremblant, Canada, June 17, 2018 - June 22, 2018. (2018)